Related references
Note: Only part of the references are listed.Different Methods of Balancing Covariates Leading to Different Effect Estimates in the Presence of Effect Modification
Mark Lunt et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
Johan Askling et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
The British Society for Rheumatology biologics register: 6 years on
K. L. Hyrich et al.
RHEUMATOLOGY (2008)
The burden of rheumatoid arthritis and access to treatment: uptake of new therapies
B. Joensson et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2008)
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor α therapy -: Results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2007)
All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists
Loreto Carmona et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis
Lennart T. H. Jacobsson et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)
J Ledingham et al.
RHEUMATOLOGY (2005)
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy - A randomized, placebo-controlled, 52-week trial
EC Keystone et al.
ARTHRITIS AND RHEUMATISM (2004)
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
L Klareskog et al.
LANCET (2004)
Adjusted survival curves with inverse probability weights
SR Cole et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)
Marginal structural models as a tool for standardization
T Sato et al.
EPIDEMIOLOGY (2003)
Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate - The ARMADA trial
ME Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2003)
Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study
HK Choi et al.
LANCET (2002)
Share Paper
